MX2007000477A - Tratamiento de tumores. - Google Patents

Tratamiento de tumores.

Info

Publication number
MX2007000477A
MX2007000477A MX2007000477A MX2007000477A MX2007000477A MX 2007000477 A MX2007000477 A MX 2007000477A MX 2007000477 A MX2007000477 A MX 2007000477A MX 2007000477 A MX2007000477 A MX 2007000477A MX 2007000477 A MX2007000477 A MX 2007000477A
Authority
MX
Mexico
Prior art keywords
metal ion
treatment
tumours
provides
ion chelating
Prior art date
Application number
MX2007000477A
Other languages
English (en)
Inventor
Russell Taylor
Paul Crees
Original Assignee
Aq & Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0415768A external-priority patent/GB0415768D0/en
Priority claimed from GB0508411A external-priority patent/GB0508411D0/en
Application filed by Aq & Plc filed Critical Aq & Plc
Publication of MX2007000477A publication Critical patent/MX2007000477A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Quinoline Compounds (AREA)

Abstract

La presente invencion proporciona el uso de un agente quelinte de ion metalico para la fabricacion de un medicamento para el tratamiento o profilaxis de un tumor canceroso mediado por bacterias, en donde dicho agente quelante de ion metalico proporciona una capacidad de quelacion del ion metalico para al menos un ion metalico del cual dicha bacteria tumorigenica depende para su viabilidad. La invencion tambien proporciona metodos para el tratamiento o profilaxis de tumores.
MX2007000477A 2004-07-15 2005-07-15 Tratamiento de tumores. MX2007000477A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0415768A GB0415768D0 (en) 2004-07-15 2004-07-15 Methods of manufacture, applications and delivery of chelating substances or compounds for the purpose of treating bacteria associated with cancerous lesions
GB0508411A GB0508411D0 (en) 2005-04-26 2005-04-26 Treatment of tumours
PCT/GB2005/002759 WO2006008470A2 (en) 2004-07-15 2005-07-15 Treatment of tumours

Publications (1)

Publication Number Publication Date
MX2007000477A true MX2007000477A (es) 2007-05-23

Family

ID=35064734

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007000477A MX2007000477A (es) 2004-07-15 2005-07-15 Tratamiento de tumores.

Country Status (11)

Country Link
US (1) US20080039508A1 (es)
EP (1) EP1771172A2 (es)
JP (1) JP2008506677A (es)
KR (1) KR20070067080A (es)
AU (1) AU2005263916A1 (es)
BR (1) BRPI0513350A (es)
CA (1) CA2581068A1 (es)
IL (1) IL180709A0 (es)
MX (1) MX2007000477A (es)
RU (1) RU2007105593A (es)
WO (1) WO2006008470A2 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060040980A1 (en) * 2004-08-20 2006-02-23 Lind Stuart E Ionophores as cancer chemotherapeutic agents
US8815936B2 (en) 2008-03-03 2014-08-26 Nad Life Pty Ltd Pharmaceutical formulations of resveratrol and methods of use thereof for treating cell disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6407125B1 (en) * 1995-12-29 2002-06-18 Novactyl, Inc. Pharmacological agent and method of treatment
US7846919B2 (en) * 1998-02-10 2010-12-07 Dermex Pharmaceuticals, Llc Chelated 8-hydroxyquinoline and use thereof in a method of treating epithelial lesions
US20020182272A1 (en) * 2001-05-30 2002-12-05 Bruce Halstead Methods of treatment of HIV-associated conditions
WO2003032944A1 (en) * 2001-10-12 2003-04-24 Aq+ Plc Anti-microbial composition comprising a metal ion chelating agent

Also Published As

Publication number Publication date
AU2005263916A1 (en) 2006-01-26
US20080039508A1 (en) 2008-02-14
KR20070067080A (ko) 2007-06-27
WO2006008470A2 (en) 2006-01-26
CA2581068A1 (en) 2006-01-26
EP1771172A2 (en) 2007-04-11
JP2008506677A (ja) 2008-03-06
BRPI0513350A (pt) 2008-05-06
WO2006008470A3 (en) 2006-03-09
IL180709A0 (en) 2008-03-20
RU2007105593A (ru) 2008-09-10

Similar Documents

Publication Publication Date Title
MX2007014132A (es) Compuestos de diarilhidantoina.
HK1117422A1 (en) Use of hif 1alfa modulators for treatment of cancer
ZA201807811B (en) Cancer treatments
SG164368A1 (en) Treatment of cancer
NO20062885L (no) Terapeufiske anti-IGFR1-antistoffkombinasjoner
MX2010000465A (es) Metodos y composiciones para el tratamiento de cancer, tumores y alteraciones relacionadas con tumores.
MX2009008347A (es) Oxabicicloheptanos y oxabicicloheptenos, su preparacion y uso.
TW200716141A (en) Compositions and methods for treatment for neoplasms
EP4364800A3 (en) Methods for treating progressive multiple sclerosis
PH12019500957A1 (en) Selective inhibitor of exon 20 insertion mutant egfr
EA201890957A1 (ru) Комбинированная терапия для лечения злокачественных опухолей
MX2008015775A (es) Compuestos y composiciones para tratamiento de cancer.
WO2007101235A3 (en) Improved antitumoral treatments
WO2007047608A3 (en) Fibrin targeted therapeutics
SI1831209T1 (sl) Zaviralci fosfataz cdc25
WO2006125813A3 (en) Tetrahydropyridothiophenes for use in the treatment of cancer
EP1968981A4 (en) METHOD FOR TREATING TUMORS WITH AZAXANTHONES
MX2022007626A (es) Combinaciones.
MX2010000956A (es) Derivados de isoftalamida que inhiben actividad de beta-secretasa.
WO2007130501A3 (en) Combination therapy for treatment of cancer
MX2010001303A (es) Compuestos terapeuticos.
MX2007000477A (es) Tratamiento de tumores.
MX2022007623A (es) Combinaciones.
UA96269C2 (uk) Інгібітори цистеїнпротеази та їх терапевтичне застосування
EP3970793A4 (en) AGENT FOR THE PREVENTION, APPEAL OR TREATMENT OF PERIODONTAL DISEASE